GLP-1 Drugs Such as Ozempic Could Influence Certain Medical Imaging Results
Medications in the GLP-1 agonist class—including Ozempic, Wegovy, Mounjaro, and Zepbound—are widely prescribed for diabetes management and weight loss. New…
Latest innovations in healthcare, medical technology, digital health, AI, and research shaping the future of medicine. Stay updated on breakthroughs that are transforming diagnosis, treatment, and patient care worldwide.
Medications in the GLP-1 agonist class—including Ozempic, Wegovy, Mounjaro, and Zepbound—are widely prescribed for diabetes management and weight loss. New…
A new report has drawn attention to an alarming connection between illicit drug use and fatal motor vehicle accidents, prompting…
When Michelle, a 42-year-old marketing executive, reviewed her grocery app one morning, she was stunned. Her weekly bill had dropped…
The U.S. Food and Drug Administration (FDA) has issued a boxed warning for Carvykti, a CAR-T cell therapy jointly developed…
Dr. Hosen Kiat is a distinguished Australian cardiologist and medical researcher whose work has had a lasting global impact on…
Structure Therapeutics Inc. (NASDAQ: GPCR) is moving closer to seeking regulatory approval for its experimental weight-loss pill, but company leadership…
NHS clinicians may soon spend more time with patients and less time typing up notes, thanks to a new wave…
NHS clinicians may soon spend more time with patients and less time typing up notes, thanks to a new wave…
The SUSA project is leading a groundbreaking educational initiative to close digital skills gaps in the European healthcare sector. This…
The UK is stepping up its bid to become a global leader in clinical trials, with new figures from the…